These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 23211716)

  • 1. Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis.
    Toczek A; Cox H; du Cros P; Cooke G; Ford N
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):299-307. PubMed ID: 23211716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies.
    Alipanah N; Jarlsberg L; Miller C; Linh NN; Falzon D; Jaramillo E; Nahid P
    PLoS Med; 2018 Jul; 15(7):e1002595. PubMed ID: 29969463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcomes for multidrug-resistant tuberculosis under DOTS-Plus: a systematic review and meta-analysis of published studies.
    Kibret KT; Moges Y; Memiah P; Biadgilign S
    Infect Dis Poverty; 2017 Jan; 6(1):7. PubMed ID: 28093078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Ecuador's national monetary incentive program on adherence to treatment for drug-resistant tuberculosis.
    Sripad A; Castedo J; Danford N; Zaha R; Freile C
    Int J Tuberc Lung Dis; 2014 Jan; 18(1):44-8. PubMed ID: 24365551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
    Kliiman K; Altraja A
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between Directly Observed Therapy and Treatment Outcomes in Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis.
    Yin J; Yuan J; Hu Y; Wei X
    PLoS One; 2016; 11(3):e0150511. PubMed ID: 26930287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: a quantitative and qualitative study.
    Sanchez-Padilla E; Marquer C; Kalon S; Qayyum S; Hayrapetyan A; Varaine F; Bastard M; Bonnet M
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):160-7. PubMed ID: 24429307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
    Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.
    Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T
    Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug-resistant tuberculosis of the spine--is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients.
    Pawar UM; Kundnani V; Agashe V; Nene A; Nene A
    Spine (Phila Pa 1976); 2009 Oct; 34(22):E806-10. PubMed ID: 19829244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.
    Brust JC; Gandhi NR; Carrara H; Osburn G; Padayatchi N
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):413-9. PubMed ID: 20202298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese herbal medicine as adjuvant treatment to chemotherapy for multidrug-resistant tuberculosis (MDR-TB): A systematic review of randomised clinical trials.
    Wang M; Guan X; Chi Y; Robinson N; Liu JP
    Tuberculosis (Edinb); 2015 Jul; 95(4):364-72. PubMed ID: 25861717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
    Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
    BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient Characteristics Associated with Tuberculosis Treatment Default: A Cohort Study in a High-Incidence Area of Lima, Peru.
    Lackey B; Seas C; Van der Stuyft P; Otero L
    PLoS One; 2015; 10(6):e0128541. PubMed ID: 26046766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Sputnik': a programmatic approach to improve tuberculosis treatment adherence and outcome among defaulters.
    Gelmanova IY; Taran DV; Mishustin SP; Golubkov AA; Solovyova AV; Keshavjee S
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1373-9. PubMed ID: 22283898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing adherence to MDR-TB treatment among patients on self-administered therapy and those on directly observed therapy: non-inferiority randomized controlled trial.
    Wekesa C; Sekaggya-Wiltshire C; Muyanja SZ; Lume I; Nabaggala MS; Parkes-Ratanshi R; Akello SA
    Trials; 2023 May; 24(1):326. PubMed ID: 37173761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients.
    Atif M; Bashir A; Ahmad N; Fatima RK; Saba S; Scahill S
    BMC Infect Dis; 2017 Sep; 17(1):655. PubMed ID: 28962599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDR-TB in Eastern Europe in the era of the TB elimination action framework.
    Dudnyk A; Butov D; Crudu V; Lange C; Chesov D
    Int J Tuberc Lung Dis; 2017 Jan; 21(1):2-3. PubMed ID: 28157456
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary resection for patients with multidrug-resistant tuberculosis: systematic review and meta-analysis.
    Xu HB; Jiang RH; Li L
    J Antimicrob Chemother; 2011 Aug; 66(8):1687-95. PubMed ID: 21642292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study.
    Bonnet M; Bastard M; du Cros P; Khamraev A; Kimenye K; Khurkhumal S; Hayrapetyan A; Themba D; Telnov A; Sanchez-Padilla E; Hewison C; Varaine F
    Int J Tuberc Lung Dis; 2016 Feb; 20(2):177-86. PubMed ID: 26792469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.